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The ethanol extract of Gongronema latifolium leaves were evaluated for anti-ulcer, analgesic and anti 
pyretic activities in rats and mice. Ethanol-induced gastric ulceration, acetic acid-induced writhing and 
formalin-induced nociception were used. Yeast-induced hyperpyrexia was used to investigate the 
antipyretic activity. The extract produced a significant ulcer protective activity in rats. The extract also 
decreased pain induced both by acetic acid in mice and early phase of formalin test in rats. A 
significant reduction in hyperpyrexia was also produced by the extract in rats. This present study 
provides a strong evidence of anti-ulcer, analgesic and antipyretic activities of G. latifolium. 
 





Gongronema latifolium, known as ‘utazi’ in the south- 
eastern and ‘arokeke’ in the south-western part of Nigeria. 
It is a tropical rainforest plant which belongs to the family 
of Aslepiadaceae (Ugochukwu and Babady, 2002, 2003). 
It is a climber with tuberous base found in deciduous 
forest from Guinea Bissau and western Cameroons. 
Various parts of these plants, particularly the stems and 
leaves are used as chewing sticks or liquor in places 
such as Sierra Leone. The liquor, usually obtained after 
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Abbreviations: I.P, Intraperitoneally; ASA, acetylsalicylic acid; 
S.C, subcutaneously; COX-2, cyclooxygenase- 2; PG, 
prostaglandin; PGE2, prostaglandin E2; LD50, half maximum 
lethal dose; SEM, standard error of mean. 
water over three days is usually taken as a purge for colic 
and stomach pains as well as to treat symptoms connected 
with worm infections (Okafor, 1975). The plant has also 
been widely used in folk medicine as a spice and 
vegetable (Morebise et al., 2002) for maintaining healthy 
blood glucose levels (Okafor, 1981, 1987, 1989). 
Antibacterial activity of the leaf extract has also been 
reported (Nwinyi et al., 2008). 
The use of medicinal plants in curing diseases is as old 
as man (Grabley and Thierickee, 1999; Abinu et al., 
2007). The World Health organization (WHO) has long 
recognized and drawn the attention of many countries to 
the ever increasing interest of the public in the use of 
medicinal plants and their products in the treatment of 
various ailments. These plants which are found in our 
environment enjoy wide acceptability by the population 
and serve as cheaper alternatives to orthodox medicine 





G. latifolium is one of such medicinal plants whose 
therapeutic application has a folkloric background. The 
plant enjoys widespread reputation as a remedy for 
inflammation, bacteria, ulcer, malaria, diabetes and 
analgesic. Hence a scientific verification of its uses would 
be important in establishing a pharmacological basis for 
some of the claimed ethnomedicinal uses. This study 
establishes a scientific basis for the folkloric use of G. 
latifolium leaves as antiulcer, pain relief and antipyretic. 
 
 




Fresh leaves of G. latifolium were collected from Ihiagwa, Owerri, 
Imo State, Nigeria. The plant was identified and authenticated by 
Mrs. Grace Ugbabe, Department of Medicinal Plant Research and 
Traditional Medicine, National Institute for Pharmaceutical Research 
and Development (NIPRD), Abuja, Nigeria. A voucher specimen 
has been deposited in NIPRD herbarium with the voucher number: 
(NIPRD (H) 6395). The leaves were air-dried and pulverized into 
fine powder. 300 g of the powdered material was macerated with 
ethanol for three consecutive days at room temperature with 
constant shaking. The liquid extract obtained was concentrated to 





The ethanolic extract of G. latifolium was subjected to qualitative 
phytochemical screening according to standard methods (Trease 





Adult wistar rats (200-250 g) and Swiss albino mice (20-25 g) of 
either sex obtained from the Animal Facility Centre of National 
institute for Pharmaceutical Research and Development (NIPRD), 
Abuja, Nigeria were used for the experiments. All animals were kept 
in metal cages at room temperature and housed under standard 
conditions of 12:12 h light/dark cycle. They were fed with NIPRD 
formulated standard feed and allowed free access to tap water ad 
libitum. Studies were carried out in accordance with the principles of 
good laboratory practice and animal handling (NIH) guidance for 




Acute toxicity studies 
 
The acute toxicity LD50 was estimated both orally (p.o) and 
intraperitoneally (i.p) in both adult Wistar rats and Swiss albino mice 
following Locke’s method (1989). Dose levels used range from 100 
to 5000 mg/kg body weight. The LD50 was calculated as the 
geometric mean of the dose that caused 100% mortality and the 
dose which caused no mortality at all.  
 
 
Ethanol induced ulceration 
 
The rats were fasted for 48 h but allowed free access to water ad 
libitum. They were randomly selected and divided into five groups 
with six animals in each group. Group 1 received normal saline 10 
ml/kg body weight while group II received standard drug (Ranitidine 
20 mg/kg). Groups III, IV and V received 100, 200 and 400 mg/kg of  




the extract, respectively, and all drugs were administered orally. 
One hour later, ulceration was induced by intragastric instillation of 
0.5 ml of 90% ethanol and 1 h after ethanol administration, rats 
were anaesthetized using ether and the stomachs were removed 
and opened along the greater curvature to macroscopically 
examine any ulcerative lesions. The number, length and severity of 
the ulcers were noted and scored on an arbitrary 0 - 6 point scale 
(Magistretti et al., 1988). The scores were as below: 
 
0 = No lesion 
1 = 1 - 3 small lesions 
2 = 1 - 3 large lesions 
3 = 1 - 3 thick lesions 
4 = More than 3 small lesions 
5 = More than 3 large lesions 
6 = More than 3 thick lesions 
 
 
Acetic acid induced writhes 
 
This test was conducted using the method described by Koster et 
al. (1959). Mice were divided into five groups of six animals each 
and pre-treated as follows: Group 1, II and III received 25, 50 and 
100 mg/kg of the extract, respectively, while IV received acetyl 
salicylic acid (ASA) 150 mg/kg and group V which served as control 
received normal saline in appropriate volumes, administered i.p. 30 
min after pre-treatment, each mouse was administered 0.7% of an 
aqueous solution of acetic acid (10 mL/Kg). Mice were then placed 
in transparent perspex observation boxes and the number of 
abdominal constrictions was counted for 10 min after treatment. 
The percentage inhibition of constrictions for the extract and ASA 
groups were calculated as: 
 
% Inhibition = [(Control mean – test mean) / Control mean] × 100 
 
 
Formalin induced nociception in rats 
 
The test was carried out as described by Dubuisson and Dennis 
(1977) and modified by Tjolsen et al. (1992). Adult Wistar rats were 
divided into five groups of six animals each and pre-treated i.p as 
follows: Group 1 received normal saline, this served as control. 
Group II, III and IV received 25, 50 and 100 mg/kg extract, 
respectively, while group V received 150 mg/kg ASA, all drugs 
administered i.p. 30 min after treatment, all groups were 
administered 50 µL of a 2.5% solution of formalin, subcutaneously 
(s.c) under the sub plantar surface of the left hind paw (Table 3). 
They were then placed in an observation chamber and monitored 
for 60 min, recording severity of nociceptive responses based on 
the observation scale below: 
 
(0) rats can bear weight on injected paw with free movement. 
(1) Light resting of the injected paw on the floor. 
(2) Partial elevation of the injected paw. 
(3) Total elevation of the injected paw, licking and /or biting of the 
injected paw. 
 
These observations were recorded every minute for the first 10 min 






The method by Al-Ghamdi (2001) was adopted to evaluate the 
antipyretic activity of the extract in rats. The rats were injected 
subcutaneously (s.c) with 10 ml/kg of 15% suspension of yeast 
(Danbaoli) to induce pyrexia. The rectal temperature of each animal




Table 1. The effect of the ethanolic extract of G. latifolium on the ethanol induced gastric ulceration in rats. 
 
Drug Dose (mg/kg) Ulcer index (U.I.) % Maximal protection of ulceration 
Control (Saline) 10 ml/kg 5.33 ± 0.33 _____ 
Ranitidine  20 0.33 ± 0.21 93.81* 
G. latifolium  100 3.17 ± 0.60 40.52* 
G. latifolium  200 1.00 ± 0.68 81.24* 
G. latifolium 400 0.50 ± 0.50 90.61* 
 




Table 2. The effect of the ethanolic extract of G. latifolium on acetic acid induced writhes in mice. 
 
Drug Dose (mg/kg) Writhes % Inhibition 
Control (saline)  10 ml/kg 31.85 ± 3.06 ____ 
ASA 150 3.33 ± 3.33 89.54 * 
G. latifolium  25 14.17 ± 1.87 55.55 * 
G. latifolium  50 9.50 ± 5.61 70.15 * 
G. latifolium 100 5.33 ± 2.15 83.25 * 
 




was taken before and 24 h after injection using a clinical ther-
mometer (Geon Corp. U.S.A). Rats that did not show a minimum 
increase of 0.5°C in temperature 24 h after yeast injection were 
screened out of the study. Thirty selected rats were grouped into 
five and treated as follows: Group I received normal saline (10 
ml/kg i.p) while group II received 20 mg/kg drugamol (Drugfield 
Nigeria) to serve as positive control. Group III, IV and V received 
25, 50 and 100 mg/kg of the extract, respectively, all administered 
i.p. The rectal temperature of each rat was again recorded at 30 





Results were expresses as mean± standard error of the mean 
(SEM). The data were analyzed using student’s t-test and 2 way 







Phytochemical analysis of the extract revealed the 
presence of alkaloids, saponins, tannins and flavanoids. 
 
 
Acute toxicity studies 
 
When administered i.p in mice, the ethanolic extract of G. 
latifolium produced 100% lethality at 2000 mg/kg and 0% 
lethality at 1000 mg/kg. Hence, the LD50 in mice was 
estimated to be 144.2 mg/kg ip. No lethality was 
observed in mice upon oral administration even at doses 
as high as 5000 mg/kg. Thus, the oral LD50 was 
estimated to be >5000 mg/kg body weight. Apart from 
weakness, G. latifolium did not produce any major signs 
of clinical toxicity over the 4 days observation period. 
 
 
Acute gastric ulcer induced by ethanol 
 
The extract was found to possess remarkable and 
significant ulcer protective properties at 200 and 400 
mg/kg body weight with maximum effect at 81.24 and 
90.61% inhibition of ulceration, respectively (P < 0.01). 
Ranitidine, the standard drug produced 93.81% protection 
(P < 0.01) (Table 1). 
 
 
Acetic acid induced writhes 
 
Dose dependent and significant antinociceptive effect 
was noticed with the ethanolic extract at the doses 
tested. In the acetic acid induced writhing model, the 
extract with 100 mg/kg dose exhibited a maximum of 
83.25% inhibition of writhing (P < 0.01) and the effect was 
comparable to standard acetylsalicylic acid (89.54%) (P < 
0.01) while 25 and 50 mg/kg doses have shown 55.55 
and 70.15% reduction, respectively (P < 0.01) (Table 2). 
 
 
Formalin induced nociception 
 
The ethanolic extract of G. latifolium significantly inhibited 
both phases of the formalin test dose dependently. In the 
early phase, the extract produced significant inhibition of 
up to 51.55% at 100 mg/kg (P < 0.01) when compared 
with ASA, which produced an  inhibition  of  58.52%  at  a  




Table 3. The effect of ethanolic extract of G. latifolium on early and late phase formalin induced pain in rats. 
 
Drug Dose (mg/kg) Early phase Pain score % Pain Inhibition Late phase Pain score % Pain inhibition 
Control (saline)  10 ml/kg 2.58 ± 0.07 _____ 2.9 ± 0.21 _____ 
ASA  150 1.07 ± 0.11 58.52 1.0 ± 0.18 65.5* 
G. latifolium  25 2.03 ± 0.24 21.32 2.53 ± 0.11 12.78 
G. latifolium  50 1.75 ± 0.25 32.17 2.47 ± 0.10 14.83 
G. latifolium  100 1.25 ± 0.20 51.55 2.22 ± 0.23 23.45* 
 
 *P < 0.01 as compared to control groups. 




Table 4. The effect of ethanolic extract of G. latifolium on yeast induced pyrexia in rats. 
 
Rectal temperature (oC) 
Drug Dose - (mg/kg) 24 h 0.0 h 0.5 h 1.0 h 1.5 h 2 h 
Control (saline) 10 mg/kg 37.15 ± 0.24 38.27 ± 0.20 37.70 ± 0.33 38.35 ± 0.21 38.57 ± 0.29 38.98 ± 0.16 
Drugamol 20 36.24 ± 0.27 37.06 ± 0.43 36.50 ± 0.14 35.91 ± 0.14 34.91 ± 0.26 34.54 ± 0.18* 
G. latifolium 25 36.81± 0.24 36.96 ± 0.35 36.11 ± 0.22 35.76 ± 0.27 35.69 ± 0.35 35.67± 0.25* 
G. latifolium 50 36.50 ± 0.18 37.76 ± 0.14 36.14 ± 0.26 35.60 ± 0.20 35.64 ± 0.34 35.10 ± 0.24* 
G. latifolium 100 36.79 ± 0.20 37.07 ± 0.35 36.15 ± 0.33 35.73 ± 0.38 35.21 ± 0.37 34.71 ± 0.40* 
 
The results given are mean ± SEM; number of animal used (n = 6). 




dose of 150 mg/kg (P < 0.01). In the late phase of 
formalin test however, there is a large difference between 
the levels of inhibition produced by the extract compared 
with ASA. The extract produced an inhibition of 23.45% 
at 100 mg/kg whilst ASA produced 65.52% at 150 mg/kg 
(P < 0.01). The extract produced pain inhibition at the 
lower doses of 25 and 50 mg/kg. 
 
 
Yeast induced pyrexia 
 
The subcutaneous injection of yeast suspension markedly 
elevated the rectal temperature of the rats after 24 h of 
administration. Treatment with the ethanolic extract of G. 
latifolium at the dose of 25, 50 and 100 mg/kg body 
weight significantly decreased the rectal temperature of 
the rat in dose dependent manner (P < 0.01). The 
antipyretic effect started from the first 30 min and was 
maintained for 120 min after extract administration. The 
result obtained from both the standard drug and the 
extract - treated rats were statistically compared with 
control group and a significant reduction in temperature 





The ethanolic extract of G. latifolium was evaluated for its 
anti-ulcer activity in rats. A significant anti-ulcer activity 
was observed for the extract in the ethanol induced ulcer 
model. Ethanol induced damage to gastric mucosa is 
associated with a significant production of free radicals 
(Szelenyi and Brune, 1988) leading to increased lipid 
peroxidation. Moreover, in the stomach, ethanol causes 
solubilization of mucus constituents and depresses tissue 
levels of proteins, leading to flow stasis in gastric blood 
(Szabo et al., 1986). Ethanol provoked gastric mucosal 
lesions are caused by the direct toxic effect of ethanol 
through the reduction in mucus production, gastric 
mucosal blood flow and bicarbonate secretion. 
Endogenous glutathione and prostaglandin (PG) levels 
are also lowered by ethanol while the release of 
histamine, influx of calcium ions and generation of free 
radicals and production of leukotrienes are all increased 
(Glavin and Szabo, 1992). 
The active constituents of the extract revealed by the 
phytochemical screening, especially tannins and flavanoids, 
may also have a contributory role to play in its anti-ulcer 
activity. Tannins are known to ‘tar’ the outermost layer of 
the gastric mucosa rendering it less permeable and more 
resistant to chemical and mechanical injury or irritant 
(Asuzu and Onu, 1990). Thus, the result of this study has 
shown that G. latifolium probably antagonizes the 
aggressive factors like acid, pepsin and H. pylori, which 
play an important role in the pathogenesis of gastric 
ulcers (Kumar and Clarke, 2002) while augmenting the 
defensive mucosal factors that protect the gastric mucosa 
from injury (Germano et al., 1998). This assertion is 
further buttressed by the fact that the extract has been 
shown to have a remarkable antimicrobial activity against 
bacteria (Escherichia, S. aureus, etc) (Nwinyi et al., 
2008). 




It is also possible that flavanoids present in G. latifolium 
may play a role in this regard. Flavanoids possess 
antioxidant properties in addition to strengthening the 
mucosal defence system through stimulation of gastric 
mucus secretion (Martin et al., 1994). Further tests 
however need to be undertaken to elucidate the exact 
mechanism of action. 
Analgesic activity is another biological property signifi-
cantly exhibited by the extract. The extract inhibited 
acetic acid induced writhing response in the animals. 
Acetic acid induced writhes is a sensitive procedure in 
detecting analgesic effect of medicinal agents (collier et 
al., 1968). This pain mechanism is believed to involve 
local peritoneal receptors (Bentley et al., 1983) caused by 
peritoneal fluid concentration of PG-E2 and PG-F2. 
(Deraedt et al., 1980). This method is not only simple and 
reliable but also affords rapid evaluation of peripheral 
type of analgesic action. In this, the animals react with 
characteristic stretching behavior which is called writhing. 
The abdominal constriction is related to the sensitization 
of nociceptive receptors in prostaglandins. It is therefore 
possible that the analgesic effect may be due to the 
inhibition of synthesis or action of prostaglandins. The 
extract was also effective in the formalin test which 
involves two phases: neurogenic with the release of sub-
stance P and inflammation with the release of serotonin, 
histamine, bradykinin and prostaglandins (Murray et al., 
1988; Tjolsen et al., 1992). It was able to block both 
phases of formalin response, although, higher inhibition 
was seen in the first phase. 
A dose dependent significant reduction in yeast-induced 
pyrexia was also observed in rats treated with the 
ethanolic leaf extract of G. latifolium. Pyrexia may be as 
result of infection or one of the sequelae of tissue 
damage, inflammation, graft rejection or other disease 
state. Antipyretics are drugs which reduce elevated body 
temperature, graft rejection or other disease state. 
Regulation of body temperature requires a delicate 
balance between production and loss of heat and the 
hypothalamus regulates the set point at which body 
temperature is maintained. Most of the antipyretic drugs 
inhibit COX-2 expression thus inhibiting PGE2 biosynthesis 
to reduce elevated body temperature. The present result 
shows that the ethanolic extract of G. latifolium 
possesses a significant antipyretic effect in yeast induced 
pyrexia in rats and its effects are comparable to that of 
drugamol. Based on the results obtained, it can be 
concluded that the ethanolic leaf extract of G. latifolium 
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